May 26, 2023 05:34 AM EDTUpdated 01:31 PM
Peer Review

Stephen Hahn’s can­cer-test­ing biotech hires a new CMO; For­mer Io­vance ex­ec named CEO of Ob­sid­i­an

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Andrew Dunn

Senior Biopharma Correspondent

Flag­ship Pi­o­neer­ing’s blood can­cer test­ing start­up Har­bin­ger Health has brought in drug in­dus­try vet­er­an May Or­fali as its new chief med­ical …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump asks 'very tough hom­bre' Dr. Oz to lead MFN talks

About 5% of CBER and CDER left af­ter FDA staff cuts, analy­sis finds

US warns drug­mak­ers against mis­rep­re­sent­ing cost of im­port­ed prod­ucts

Merus’ Phase 2 over­all sur­vival da­ta reach ‘home run’ sce­nario — an­a­lyst

Ge­of­frey Porges ex­its Schrödinger with CFO swap; A new board seat for As­traZeneca's Pas­cal So­ri­ot

sponsored

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

A service from the Financial Times